In the Matter of the Child of: M. E. P. and T. H. V., Parents

CourtCourt of Appeals of Minnesota
DecidedFebruary 26, 2024
Docketa231176
StatusPublished

This text of In the Matter of the Child of: M. E. P. and T. H. V., Parents (In the Matter of the Child of: M. E. P. and T. H. V., Parents) is published on Counsel Stack Legal Research, covering Court of Appeals of Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In the Matter of the Child of: M. E. P. and T. H. V., Parents, (Mich. Ct. App. 2024).

Opinion

STATE OF MINNESOTA IN COURT OF APPEALS A23-1176

In the Matter of the Child of: M. E. P. and T. H. V., Parents.

Filed February 26, 2024 Affirmed Johnson, Judge

Wright County District Court File No. 86-JV-23-591

Lucas J.M. Dawson, Christina Zauhar, Halberg Criminal Defense, Bloomington, Minnesota (for appellant parents)

Brian A. Lutes, Wright County Attorney, Lindsey R. Danielson, Assistant County Attorney, Buffalo, Minnesota (for respondent Wright County Health and Human Services)

John Jerabek, Tuft, Lach, Jerabek & O’Connell, Maplewood, Minnesota (for guardian ad litem)

Considered and decided by Johnson, Presiding Judge; Segal, Chief Judge; and

Cochran, Judge.

SYLLABUS

1. The district court did not err by determining that a five-year-old child with

an aggressive form of cancer is in need of protection or services because his parents had

rejected a physician’s recommendation that the child continue to receive a chemotherapy

treatment that is widely accepted for the child’s type of cancer and likely is necessary for

the child’s survival.

2. The district court’s order requiring chemotherapy treatment for a five-year-

old child with an aggressive form of cancer, over his parents’ objection, does not violate

the parents’ constitutional rights to the care, custody, and control of their child in light of the district court’s findings that the chemotherapy treatment is well accepted in the medical

community and that the child’s probability of survival is more than 90 percent with the

treatment and less than 20 percent without the treatment.

OPINION

JOHNSON, Judge

When K.K.P. was four years old, he was diagnosed with leukemia. He began a five-

phase chemotherapy treatment, which has a survival rate of more than 90 percent, as

compared to a survival rate of less than 20 percent without the treatment. K.K.P.’s parents

decided to discontinue chemotherapy after he had completed the first phase of the

treatment. Wright County petitioned the district court for an order adjudicating K.K.P. a

child in need of protection or services and an order requiring the continuation of

chemotherapy. Following an emergency protective-care hearing, the district court granted

interim legal custody of K.K.P. to the county, placed him in foster care with a relative, and

ordered that he continue to receive the recommended chemotherapy. Later, after a four-

day trial, the district court granted the county’s petition and reiterated its prior orders.

K.K.P.’s parents appeal. We conclude that the district court did not err by adjudicating

K.K.P. a child in need of protection or services or by ordering an out-of-home placement.

We also conclude that the district court’s orders requiring chemotherapy do not violate the

parents’ constitutional rights to the care, custody, and control of their child. Therefore, we

affirm.

2 FACTS

K.K.P. is now six years old. Before the events that precipitated this action, he lived

with his mother, M.E.P., his father, T.H.V., and a younger brother, traveling as necessary

for T.H.V.’s work in the oil-and-gas industry in Texas, Oklahoma, and nearby states.

In December 2022, K.K.P. and his family traveled to Wright County, Minnesota to

visit relatives who reside there. On December 16, K.K.P.’s mother took him to a

pediatrician because he had been ill for three weeks and she had observed swollen lymph

nodes and a rash on his body. The pediatrician performed a blood test, which indicated a

dangerously high white-blood-cell count. While in the pediatrician’s examination room,

K.K.P. became “really sleepy” and “couldn’t stay awake.” K.K.P. went to Children’s

Hospital in Minneapolis by ambulance.

At Children’s Hospital, K.K.P. was diagnosed as having had a hemorrhagic stroke.

He was admitted to the pediatric intensive care unit (PICU). Soon thereafter, he was

diagnosed with T-Cell Acute Lymphoblastic Leukemia (T-Cell ALL), an aggressive form

of cancer that likely results in death if left untreated. While in the PICU, K.K.P. underwent

leukapheresis, a procedure that filters and removes white blood cells from the body, and

he was given a steroid to reduce swelling in and around his brain.

K.K.P.’s treatment was overseen by Nathan Gossai, M.D., a physician with

expertise in T-Cell ALL and the director of the leukemia and lymphoma program at

Children’s Hospital. Dr. Gossai recommended a chemotherapy treatment protocol that is

associated with a 93 percent chance of survival, which K.K.P.’s parents initially approved.

3 As explained by Dr. Gossai at trial, the chemotherapy protocol for T-Cell ALL

consists of five phases. The first phase, induction, is intended to “quickly and efficiently

. . . remove the leukemia from the peripheral bloodstream, and ideally from the bone

marrow,” so that the leukemia no longer is detectable. The cancer is considered not

detectable if 0.02 percent or fewer of the 500,000 white blood cells in a tested sample

indicate the presence of the disease. Because there are billions of white blood cells in a

human body, a determination that cancer is not detectable does not mean that cancer is not

present in a patient’s body.

The second phase of the chemotherapy treatment recommended by Dr. Gossai,

consolidation, uses various medications to keep residual leukemia in the blood and bone

marrow “at bay,” while focusing on treating the spinal fluid through “four consecutive

weekly lumbar punctures, that include the administration of chemotherapy.” The third

phase, interim maintenance, involves the intravenous administration of medication to treat

the blood, bone marrow, and cerebrospinal fluid. The fourth phase, delayed intensification,

is intended “to continue to stay ahead of a potentially evolving leukemia while treating

leukemia that may well be undetectable,” by utilizing “different medications on different

structures, timeframes, and methodologies.” The fifth and final phase, maintenance,

involves oral medications given at home, intravenous medication once per month, and

chemotherapy delivered via lumbar puncture once every three months.

K.K.P. began the T-Cell ALL chemotherapy treatment protocol on December 20,

2022. He was discharged from the hospital on January 10, 2023, and he completed the first

phase of treatment at a Children’s Hospital clinic soon thereafter. K.K.P. experienced

4 numerous side effects during the first phase of treatment, including fatigue, poor appetite,

nausea, vomiting, muscle weakness (myopathy), short-term neuropathy, and irritation of

the bladder (cystitis).

K.K.P. was scheduled to begin the second phase of chemotherapy treatment on

January 23, 2023. But he did not begin the second phase on that date because his parents

objected based on concerns about the efficacy of the treatment and the severity of its side

effects. K.K.P.’s mother expressed a preference for natural remedies, and she consulted

with a naturopathic doctor, Helen Healy, N.D., 1 with whom she discussed herbs and

supplements that might be used to treat K.K.P. K.K.P.’s mother discussed potential

alternative therapies with Dr. Gossai, such as the use of garlic and lemon. Dr. Gossai

engaged in ongoing discussions with K.K.P.’s parents about the necessity of chemotherapy

treatment. He discussed “the risks and benefits of therapy,” including potential side effects.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Parham v. J. R.
442 U.S. 584 (Supreme Court, 1979)
Troxel v. Granville
530 U.S. 57 (Supreme Court, 2000)
State, Department of Human Services v. Hamilton
657 S.W.2d 425 (Court of Appeals of Tennessee, 1983)
Thiele v. Stich
425 N.W.2d 580 (Supreme Court of Minnesota, 1988)
In Re Custody of NAK
649 N.W.2d 166 (Supreme Court of Minnesota, 2002)
Custody of a Minor
379 N.E.2d 1053 (Massachusetts Supreme Judicial Court, 1978)
In Re the Welfare of the Children of S.E.P.
744 N.W.2d 381 (Supreme Court of Minnesota, 2008)
Soohoo v. Johnson
731 N.W.2d 815 (Supreme Court of Minnesota, 2007)
Newmark v. Williams
588 A.2d 1108 (Supreme Court of Delaware, 1991)
In Re Welfare of Doege
240 N.W.2d 562 (Supreme Court of Minnesota, 1976)
In Re Willmann
493 N.E.2d 1380 (Ohio Court of Appeals, 1986)
Jason S. v. Valley Hospital Medical Center
87 P.3d 521 (Nevada Supreme Court, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
In the Matter of the Child of: M. E. P. and T. H. V., Parents, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-the-matter-of-the-child-of-m-e-p-and-t-h-v-parents-minnctapp-2024.